Monopar Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $140.7M
Liabilities Breakdown FY2025
Total Liabilities: $2.9M
Asset Breakdown
Total Assets: $140.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $61.8M | 43.9% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $78.9M | 56.1% |
Liabilities Breakdown
Total Liabilities: $2.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $2.9M | 100.0% |